BIOD351 Module 2 FINAL TEST READINESS EXAM Q & S 2026/2027

BIOD351 Module 2 FINAL TEST READINESS EXAM Q & S 2026/2027
1. Multiple Choice: Which nonprescription medication is
considered first-line therapy for the treatment of intermittent
mild allergic rhinitis?
 a) Oral decongestants
 b) Nasal corticosteroids
 c) Antihistamines
 d) Nasal anticholinergics
 Answer: b) Nasal corticosteroids
2. True/False: Diphenhydramine is an appropriate firstchoice treatment for insomnia due to its safety profile.
 Answer: False
3. Fill-in-the-Blank: ________ is the preferred
nonprescription analgesic for patients with a history of
peptic ulcer disease.
 Answer: Acetaminophen
4. Multiple Response: Select all that apply. Which of the
following are recognized side effects of over-the-counter
NSAIDs?
 a) Gastrointestinal bleeding
 b) Hepatotoxicity
 c) Drowsiness
 d) Hypertension
 Answers: a) Gastrointestinal bleeding, d) Hypertension
5. Multiple Choice: Loratadine and cetirizine are examples
of which generation of antihistamines?
 a) First-generation
 b) Second-generation